Industry News
Alchemia granted oncology patent extension
The US patent office has granted Alchemia (ASX:ACL) an extension for a key patent covering its HyACT oncology platform through to 2025. [ + ]
Alchemia anticoagulant launches in India
Alchemia’s (ASX:ACL) marketing partner, Dr Reddy’s, has launched generic fondaparinux in India, marking its debut in a market outside of the US. [ + ]
2013 Medical Device Commercialisation Seminar Series starts today
The 2013 Medical Device Commercialisation Seminar Series explores what it takes to be one of the medical device success stories, helping today’s inventors fast-track to commercialisation. [ + ]
$100 million allocated for new tranche of investment fund
As part of the federal government’s recently announced industry and innovation plan ‘A Plan for Australian Jobs’, in which it announced a new $350 million round of the Innovation Investment Fund (IIF), $100 million has now been allocated. [ + ]
In search of outstanding glass researchers
The Otto Schott Research Award, bestowed for the first time in 1991, honours outstanding scientific achievements in the field of international glass research every two years. [ + ]
Applikon Biotechnology acquires biotech portfolio from HaloteC Instruments
Bioreactor systems company Applikon Biotechnology has signed a definitive agreement to acquire the biotechnology portfolio of HaloteC Instruments, a Dutch provider of instruments and software solutions for the biotech market. [ + ]
Up to $10 million in cancer research funding available through ACRF
The Australian Cancer Research Foundation (ACRF) has begun accepting applications for their 2013 annual Cancer Research Grant Round. [ + ]
Catalyst in a teacup: new approach to chemical reduction
Taking their inspiration from nature, scientists at the University of New South Wales have developed a new method for carrying out chemical reduction - an industrial process used to produce fuels and chemicals that are vital for modern society. [ + ]
Philanthropy, advocacy and vision
Research Australia has formed a collaborative international alliance with three advocacy groups. [ + ]
Applications open for cancer research funding
The 2013 round of funding from the Australian Cancer Research Foundation is now open. [ + ]
Funding boost for start-ups
At least $200 million will be invested in start-up companies under the latest tranche of the federal government’s Innovation Investment Fund. [ + ]
New centre for biodiversity research
CSIRO and the Australian National University have launched a new centre for biodiversity research. [ + ]
Phosphagenics in talks for TPM-diclofenac deal
Phosphagenics (ASX:POH) and Japan’s Nippon Zoki have progressed to the negotiation stage in their tie-up to produce an anti-inflammation product for the US market. [ + ]
Calzada completes treatment in NovoSorb trial
Calzada’s (ASX:CZD) PolyNovo unit has wrapped up a human trial involving using NovoSorb in vacuum-assisted closure of pressure sores. [ + ]
Biolife breast cancer vaccine validated in journal
The class of HER2/neu breast cancer vaccines to which Biolife Science’s HER-Vaxx belongs has been endorsed in a key breast cancer journal. [ + ]
